Insiders · Profile

Barone Francesca

Chief Scientific Officer at Candel Therapeutics. Filing since 8 Dec 2022. CIK 0001909680

Company
Date
Role
Action
Shares
Amount
Of holding
29 Jun 2026
Chief Scientific Officer
Sold on a plan
23,447
$235.77K
23.3%
18 Mar 2025
Chief Scientific Officer
Sold on a plan
32,146
$281.67K
25.0%
15 Jan 2025
Chief Scientific Officer
Sold at will
13,534
$97.78K
10.9%
8 Jan 2025
Chief Scientific Officer
Sold at will
13,673
$112.37K
9.9%
29 Nov 2024
Chief Scientific Officer
Sold at will
22,081
$100.59K
13.8%
17 Jul 2024
Chief Scientific Officer
Sold at will
14,051
$90.95K
8.1%
11 Jul 2024
Chief Scientific Officer
Sold at will
12,645
$75.53K
6.8%
8 Dec 2022
Chief Scientific Officer
Bought
1,238
$1.99K
82.5%
8 decisions on file.